Tepezza® Infusion Therapy for Thyroid Eye Disease
Thyroid eye disease (TED), also known as Graves' ophthalmopathy or Graves' eye disease, is an autoimmune condition that primarily affects the eyes, causing a range of uncomfortable symptoms. If you or your patient has been diagnosed with thyroid eye disease, Tepezza® infusion therapy is a highly effective treatment with a low risk of side effects. At CPS Infusion, we offer Tepezza® infusion therapy for thyroid eye disease at all of our conveniently located centers in the greater Atlanta, GA, area.
What Is Thyroid Eye Disease?
Thyroid eye disease is often associated with Graves' disease, an autoimmune thyroid disorder that leads to overproduction of thyroid hormone. This causes the immune system to mistakenly target and attack the tissues around the eyes.
Diagnosing Thyroid Eye Disease
Bulging eyes, swelling of the eyelids, eye redness and pain, difficulty moving the eyes, double vision, sensitivity to light, dry eyes, and excessive tearing are all symptoms that eye specialists look for when diagnosing thyroid eye disease. In addition to a physical test and eye exam, the eye doctor may take eyelid measurements, an ultrasound of the eyes, computed tomography imaging, and magnetic resonance imaging.
Treating Thyroid Eye Disease
Eye doctors work with the patient’s endocrinologist and primary care physician to develop the best treatment plan for the patient’s unique needs. When eye drops, medications, and supplements don’t offer good results for thyroid eye disease, Tepezza® infusion therapy can be an excellent option. Tepezza® (teprotumumab-trbw) is the first and only FDA-approved medication used to treat thyroid eye disease.
How Tepezza® Works
Tepezza® contains thyroid stimulating hormone receptors (TSHR) and insulin growth-like factor 1 receptors (IGFR-1). These mediators bind to the receptors in the tissues with cells behind the eyes, preventing them from staying active so they don’t cause inflammation of the muscles and fat in and around the eyes.
What to Expect?
- When you come to CPS Infusion, we will take you to one of our comfortable treatment rooms.
- To start your infusion therapy, our certified nurses administer Tepezza® through an IV.
- Each infusion session typically takes 60 to 90 minutes.
- The medication dosage, number of sessions, and amount of time between treatments will depend on your physician’s prescription.
Why Patients Choose Us for Tepezza® Infusion Therapy
At CPS Infusion, we take care of everything involved in your treatment so all you have to do is show up at one our conveniently located offices at your scheduled appointment time. When you receive Tepezza® infusion therapy for thyroid eye disease, you can expect:
- Comfort: At our office, treatment feels less intimidating and comfortable because it’s in a non-hospital setting.
- Personalized, patient-centered treatment: Your treatment will be customized to your unique needs by your physician team so you receive the proper dosage on the schedule that your specialist recommends.
- Care coordination team: Our staff will gather your health insurance information and check with your policy holder to get you maximum coverage for your treatment. We will advise you of any out-of-pocket expenses before you start treatment, and we can work with you to get financial assistance if available.
Why Referring Physicians Choose Us
Run By Physicians for Physicians
Our streamlined process ensures that your patient get treated promptly and with their best interests in mind. Our expert administrative staff will handle all health insurance inquiries. We also order pre-infusion and monitoring tests quickly so your patients receive the best care possible. In addition to expediting the approval process for the medication, our physicians are available for any medical issues that arise during the infusion process. Although the majority of infusions are completed without incident, patients and referring physicians receive peace of mind knowing a physician is accessible throughout the delivery of these state-of-the-art medical treatments.